Stocktoria

Jazz Pharmaceuticals plc JAZZ

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2012-01-18

Jazz Pharmaceuticals plc statistics & valuation

Market cap$14.4B
P / S3.4×
P / B3.3×
P / FCF11.1×
Net margin-8.3%
Return on equity-8.2%
FCF margin30.4%
Net debt$4.0B
Enterprise value USD$18.4B
Earnings yield EBIT/EV-2.3%
Return on capital-4.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
26.70% 30.10% 23.60% 24.20% 10.10% -10.70% -6.10% 10.80% 13.80% -8.30% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
39.80% 32.70% 32.50% 24.60% 16.00% 5.50% -1.80% 15.10% 17.60% -10.10% 2016201720182019202020212022202320242025
Return on equity (%)
21.10% 18.00% 16.20% 16.80% 6.50% -8.30% -7.30% 11.10% 13.70% -8.20% 2016201720182019202020212022202320242025
Shares outstanding
61.9M 61.3M 61.2M 57.5M 56.5M 61.6M 63.2M 72.1M 66.0M 61.4M 2016201720182019202020212022202320242025
Net debt ($)
$1.66B $1.20B $1.29B $969.9M $1.04B $5.46B $4.84B $4.21B $3.70B $3.97B 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
8.30% 9.50% 8.60% 9.40% 3.70% -2.70% -2.10% 3.60% 4.70% -3.10% 2016201720182019202020212022202320242025
Free cash flow margin (%)
41.20% 34.10% 37.40% 24.30% 34.00% 27.90% 33.40% 30.40% 2016201720182019202020212022202320242025
Debt / equity (×)
1.08× 0.58× 0.58× 0.52× 0.57× 1.53× 1.86× 1.53× 1.49× 1.24× 2016201720182019202020212022202320242025
EPS ($)
$6.41 $7.96 $7.30 $9.09 $4.22 -$5.52 -$3.58 $6.10 $8.65 -$5.84 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

Jazz Pharmaceuticals plc trades at about 28.8× earnings — above its 10-year norm (10-year range 14.4×–182.1×, median 20.1×).

14.4× 182.1×

Shaded band = 10-year range (14.4×–182.1×); dot = today's 28.8×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-10.1%17.6%15.1%-1.8%5.5%16.0%24.6%32.5%32.7%39.8%
Net margin-8.3%13.8%10.8%-6.1%-10.7%10.1%24.2%23.6%30.1%26.7%
FCF margin30.4%33.4%27.9%34.0%24.3%37.4%34.1%41.2%——
Return on assets-3.1%4.7%3.6%-2.1%-2.7%3.7%9.4%8.6%9.5%8.3%
Return on equity-8.2%13.7%11.1%-7.3%-8.3%6.5%16.8%16.2%18.0%21.1%
Debt / equity1.24×1.49×1.53×1.86×1.53×0.57×0.52×0.58×0.58×1.08×
Current ratio1.864.462.242.793.234.344.473.573.292.91

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.